Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures
Go back to Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures| Edwards Lifesciences (NYSE: EW) | Delayed: 84.41 -2.36 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.77 | 52 Week High | $166.87 | |||
| Open | $87.51 | 52 Week Low | $72.20 | |||
| Day High | $87.76 | P/E | 24.54 | |||
| Day Low | $83.81 | EPS | $3.44 | |||
| Volume | 3,079,001 | |||||
